The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Wezlana
Australian Public Assessment Report
Device/Product Name
Wezlana
Active ingredients
Ustekinumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-00167-1-1
Submission Type
Biosimilar medicine
Decision
Approved